Schering Plough Corp.

Headquarters location: One Giralda Farms Madison, NJ 07940 Tel. 973-822-7000 Job offers, investor relations: www.sch-plough.com Stock:

Schering Plough belongs to shareholder country     % source Barclays Plc 3.33 Barrow, Hanley, Mewhinney & Strauss Inc. 2.19 Capital Research & Management Inc. 2.39 Deutsche Bank AG 1.66 Dodge & Cox 3.34 FMR Corp. (Fidelity Investments) 5.77 Massachusetts Financial Services 3.51 State Street Corp. 2.51 Vanguard Group Inc. 1.8 Wellington Management Co. 9.23	Brands name items photo compare the prices Afrin Ethishop Bain de Soleil Ethishop Canji Ethishop Chlor-Trimeton Ethishop Chlor-Trimeton Ethishop Clarinex Ethishop Claritin Ethishop Clarityne Ethishop Coppertone Ethishop Correctol Ethishop Drixoral Ethishop Intron A Ethishop Lotrimil Ethishop Nasonex Ethishop NeoGenesis Pharmaceuticals Ethishop Organon Biosciences Ethishop Proventil Ethishop Ralgro Ethishop Remicade Ethishop Schering-Plough Ethishop Scholl Ethishop Solarcaine Ethishop Tinactin Ethishop Vancenase Ethishop Vanceril Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF SCHERING_PLOUGH , group and subsidiaries [?] 4% Job: 4% of company's jobs cut since 1998 1 Environment: 1 major pollution(s) 2 Delinquency: 2 act(s) of financial or trade delinquency 10 Tax haven, secret bank account, shell companies: operates in 10 offshore financial center(s) 11 Sales: more than 11 billion(s) dollars/euros in annual sales 9 Net profit: more than 9 billion(s) dollars/euros in cumulated net profit since 1998 487 Top management: earns 487 times the median income in the United States (32000 US$/year) 7 Influence: 7 act(s) of direct corruption or lobbying 2 Advertising & marketing: 2 dubious practice(s) Full profile >>>
Relevance: business & market share year business source 2006 Schering Plough is the world's sixteenth-largest pharmaceutical group. Les Echos World locations & Manufacturing country incentive : address & contact : production type source SOL Ltd : Garden Insurance Co., Ltd : Schering-Plough China, Ltd : Schering-Plough Animal Health Ltd : Key Pharmaceuticals Export Co., Inc : Dublin : R&D Les Echos Rathdrum : R&D Les Echos Inishannon : R&D Les Echos Loftus Bryan Chemicals Ltd : Schering-Plough Pensions Ireland Ltd : Avondale Chemical Co., Ltd : Chemibiotic (Ireland) Ltd : Mallinckrodt Veterinary Ltd :   DISTRITO FEDERAL XOCHIMILCO 16 DE SEPTIEMBRE 301 XALTOCAN & 015 7284444 : Schering-Plough S.A : Colombia Veterinary Holdings, Inc : Schering-Plough S.A : Schering-Plough Corp : Essex Pharmaceuticals, Inc : Plough Consumer Products (Philippines) Inc : Schering-Plough Animal Health, Inc : 2 usines : Zetia, Peg-Intron, Remicade Les Echos Schering-Plough Animal-Health Pte. Ltd : Werthenstein Chemie A.G : Trading Pharma AG : Schering-Plough Ltd : Plough Services AG : Scherico, Ltd : Schering-Plough Central East A.G : Essex Chemie A.G : Giralda Investments Ltd : Sentipharm A.G : Schering-Plough S.A : The map of tax haven, secret accounts and shell companies Schering Plough is managed by year name photo position; compensation source 2002Connors, Joseph Président du Conseil; salary: 1.58 million US$; stock-options: 0.95 million US$; 2002Hassan, Fred Chief Executive Officer; 2002Wyszomierski, Jack Chief Financial Officer; salary: 1.56 million US$; 2000D'Andrade, Hugh Chief Operating Officer; 1998Kogan, Richard Jay Chief Executive Officer; salary: 15.59 million US$; Forbes 1984D'Andrade, Hugh Director; Highest paid executives in 2007 Advertising & marketing year dubious practice : image source 2006 Deceptive advertising: Plainte collective pour publicité mensongère contre la marque de crème solaire Coppertone aux Etats-Unis, accusée de faire croire à leurs utilisateurs qu'ils sont protégés contre les maladies de peau. Son étiquette est "clairement trompeuses" dans la mesure où elle fait croire que "la crème fait écran contre tous les méfaits des rayons solaires", alors qu'elle ne protège que contre les coups de soleil, a déclaré l'un des avocats. Les auteurs de la plainte demandent que des termes comme "écran total", "waterproof" ou toute autre déclaration prêtant à confusion disparaissent des étiquettes. Ils réclament aussi que le fabricant soit contraint de "restituer l'argent frauduleusement obtenu" en finançant une fondation pour la recherche sur les cancers de la peau.: AFP 2002 Disinformation: PR campaign with Précision PR: public relations: P CB-News 2001 ad budget: 236 million US$; Advertisin. 2000 ad budget: 263 million US$; Advertisin. Dubious practices in 2007

Made by year employees <> social impact : country source 2007 52200 Les Echos 2006 33500 Les Echos 2006 -1100 Internal restructuring: Schering-Plough will streamline or phase out operations at its manufacturing facilities in Puerto Rico and New Jersey. The plan will cost $250 million and save the company $100 million a year.: United States of America Reuters 2004 -200 AP 2004 -170 Ireland The Irish . 2003 -900 Internal restructuring: AP 2002 30500 2000 28100 1989 -105 Canadian L. Layoff plans and labour conditions in 2007 Environmental impact year country : consequences source 2001 United States of America brand: Ralgro : Cancérigène (cancer du sein et de la prostate) Pollutions in 2007 Influence year purpose : intermediary/lobby : institution source 2001 Access to foreign market (through MAI, WTO, GATS), prevent binding environmental regulations : USCIB (US Council For International Business) : : US Government translate USCIB 2000 Lobbying of US authorities to extend the patent protection of its antiallergic Clarityne (sales of 2 billion US$ per year) by 3 years. : amount: 4300 thousand US$ translate Le Monde D. 2000 Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate Washington. 2000 lift the ban on bovine growth hormon : FEDESA : : European Commission translate Fedesa 2000 Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translate EFPIA 1998 Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 170 thousand US$ : US President, Congress, Senate translate Center for. 1997 Legislation favorable to company's interests : Direct donation : amount: 2683 thousand US$ : US President, Congress, Senate translate Center for. 1997 Legislation favorable to company's interests : Direct donation : amount: 265 thousand US$ : US President, Congress, Senate translate Center for. Influence in 2007 Financials year financial misdemeanor sales income source 2006   10.6   billion Eu€ Les Echos 2005 Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said. Shering-Plough settles the case for 435 million dollars.     Bloomberg 2004   -0.9   billion US$ Les Echos 2003   8.33 -0.09   billion US$ 2002   10.18 1.97   billion US$ 2002 Allegedly sold misbranded medicines, submitted false pricing data or offered free samples to lure customers     Bloomberg 2001   9.8 1.94   billion US$ 2000   9.82 2.42   billion US$ 1999   9.18 2.11   billion US$ 1998   8.08 1.76   billion US$ Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Target   Target writes off 8.1% of its annualized credit card debt in March - Friday 2 May 2008 at 11h07

Dell computer   Dell confirms plan to cut 250 Irish jobs - Friday 2 May 2008 at 08h50

Henry   leatest profile of hery sy - Tuesday 29 April 2008 at 07h08

Dow jones   Wall Street Journal managing editor stepping down - Tuesday 22 April 2008 at 08h09

Lehman brothers   Lehman liquidates three funds - Thursday 17 April 2008 at 14h46

All comments